Summit Securities Group’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,400
Closed -$14K 452
2024
Q1
$14K Buy
+3,400
New +$14K ﹤0.01% 202